60 Degrees Pharmaceuticals, Inc.
SXTP
$0.97
$0.00-0.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.76% | 26.10% | 7.32% | -0.72% | -397.33% |
| Total Depreciation and Amortization | 53.65% | 57.53% | 30.14% | 5.62% | -18.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.53% | -96.50% | -78.52% | -63.22% | 135.10% |
| Change in Net Operating Assets | -1,055.64% | -348.95% | -102.86% | -85.43% | 108.38% |
| Cash from Operations | -37.82% | -30.93% | -21.27% | -66.80% | -3.60% |
| Capital Expenditure | -87.93% | -57.00% | -34.78% | 62.41% | 56.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -392.69% | -23.44% | 122.11% | 193.82% | 60.82% |
| Cash from Investing | -194.48% | -43.67% | 113.49% | 183.09% | 58.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.23% | 18.14% | -8.48% | -14.95% | -27.74% |
| Repurchase of Common Stock | 100.00% | 100.00% | -- | 88.03% | 88.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -95.80% |
| Cash from Financing | 18.44% | 18.45% | -8.73% | -15.21% | -13.02% |
| Foreign Exchange rate Adjustments | 16.90% | 366.28% | 1,320.00% | -88.54% | -88.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -341.97% | -120.44% | 69.07% | -24.68% | -74.94% |